The clinical utility of the biomarker Fecal Calprotectin  in patients with Undifferentiated Spondyloarthritis: Relevance and clinical implications

Yasser Emad; Yasser Ragab; Nevin Hammam; Nashwa K. El Shaarawy; M. Fawzi; A. Amer; H. El-Makhzangy; A. Ismail; Osama Ibrahim; Y. Hassan; A. Kamal; J.J. Rasker

doi:10.1016/j.reumae.2020.10.005

The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis: Relevance and clinical implications

Yasser Emad, Yasser Ragab, Nevin Hammam, Nashwa K. El Shaarawy, M. Fawzi, A. Amer, H. El-Makhzangy, A. Ismail, Osama Ibrahim, Y. Hassan, A. Kamal, J.J. Rasker

Psychology, Health & Technology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	69-76
Journal	Reumatologia Clinica
Volume	18
Issue number	2
DOIs	https://doi.org/10.1016/j.reumae.2020.10.005
Publication status	Published - 1 Feb 2022

Keywords

n/a OA procedure

Access to Document

10.1016/j.reumae.2020.10.005

Cite this

Emad, Y., Ragab, Y., Hammam, N., El Shaarawy, N. K., Fawzi, M., Amer, A., El-Makhzangy, H., Ismail, A., Ibrahim, O., Hassan, Y., Kamal, A., & Rasker, J. J. (2022). The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis: Relevance and clinical implications. Reumatologia Clinica, 18(2), 69-76. https://doi.org/10.1016/j.reumae.2020.10.005

Emad, Yasser ; Ragab, Yasser ; Hammam, Nevin ; El Shaarawy, Nashwa K. ; Fawzi, M. ; Amer, A. ; El-Makhzangy, H. ; Ismail, A. ; Ibrahim, Osama ; Hassan, Y. ; Kamal, A. ; Rasker, J.J. / The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis : Relevance and clinical implications. In: Reumatologia Clinica. 2022 ; Vol. 18, No. 2. pp. 69-76.

@article{27cf6f8b2a5740a598eae2310fb88c25,

title = "The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis: Relevance and clinical implications",

keywords = "n/a OA procedure",

author = "Yasser Emad and Yasser Ragab and Nevin Hammam and {El Shaarawy}, {Nashwa K.} and M. Fawzi and A. Amer and H. El-Makhzangy and A. Ismail and Osama Ibrahim and Y. Hassan and A. Kamal and J.J. Rasker",

year = "2022",

month = feb,

day = "1",

doi = "10.1016/j.reumae.2020.10.005",

language = "English",

volume = "18",

pages = "69--76",

journal = "Reumatologia Clinica",

issn = "1699-258X",

publisher = "Ediciones Doyma, S.L.",

number = "2",

}

Emad, Y, Ragab, Y, Hammam, N, El Shaarawy, NK, Fawzi, M, Amer, A, El-Makhzangy, H, Ismail, A, Ibrahim, O, Hassan, Y, Kamal, A & Rasker, JJ 2022, 'The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis: Relevance and clinical implications', Reumatologia Clinica, vol. 18, no. 2, pp. 69-76. https://doi.org/10.1016/j.reumae.2020.10.005

The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis : Relevance and clinical implications. / Emad, Yasser; Ragab, Yasser; Hammam, Nevin; El Shaarawy, Nashwa K.; Fawzi, M.; Amer, A.; El-Makhzangy, H.; Ismail, A.; Ibrahim, Osama; Hassan, Y.; Kamal, A.; Rasker, J.J.

In: Reumatologia Clinica, Vol. 18, No. 2, 01.02.2022, p. 69-76.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The clinical utility of the biomarker Fecal Calprotectin in patients with Undifferentiated Spondyloarthritis

T2 - Relevance and clinical implications

AU - Emad, Yasser

AU - Ragab, Yasser

AU - Hammam, Nevin

AU - El Shaarawy, Nashwa K.

AU - Fawzi, M.

AU - Amer, A.

AU - El-Makhzangy, H.

AU - Ismail, A.

AU - Ibrahim, Osama

AU - Hassan, Y.

AU - Kamal, A.

AU - Rasker, J.J.

PY - 2022/2/1

Y1 - 2022/2/1

KW - n/a OA procedure

U2 - 10.1016/j.reumae.2020.10.005

DO - 10.1016/j.reumae.2020.10.005

M3 - Article

VL - 18

SP - 69

EP - 76

JO - Reumatologia Clinica

JF - Reumatologia Clinica

SN - 1699-258X

IS - 2

ER -